Pacemaker market to reach $6.8 billion by 2030

The implantable heart pacemaker market is projected to rise from $5.14 billion in 2025 to $6.8 billion by 2030, driven by aging populations, more cardiac arrhythmias and wider use of connected care. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Implantable heart pacemakers help regulate irregular or slow heartbeats, making them a core treatment for patients with cardiac rhythm disorders. - The market’s growth points to rising demand for cardiac devices, remote monitoring and less invasive treatment options. - Hospitals remain a key channel for adoption, so market expansion tracks broader investment in cardiac care infrastructure.

What happened: - The Business Research Company released a report on the implantable heart pacemaker market covering 2026-2035. - The market was valued at $5.14 billion in 2025 and is projected to reach $5.45 billion in 2026. - The report forecasts the market will grow to $6.8 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region in the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - Historical growth has been driven by rising cardiac arrhythmias, an aging global population, wider access to implantable cardiac devices, more cardiac care facilities and better surgical implantation techniques. - The forecast period is supported by demand for minimally invasive cardiac devices, broader adoption of connected healthcare technologies and expanded remote patient monitoring programs. - Personalized cardiac therapies and ongoing gains in battery efficiency and power management are also expected to support growth. - The report highlights remote cardiac monitoring pacemakers, leadless pacemaker systems, wireless data transmission, MRI-compatible devices, miniaturization and longer battery life as major trends. - An implantable heart pacemaker is surgically placed in the chest and sends electrical signals to keep the heart beating at a steady rhythm. - The device supports cardiovascular function and overall health in patients with certain heart conditions. - Hospitals use implantable pacemakers to manage heart rhythm abnormalities, monitor heart function remotely and improve patient quality of life. - In August 2023, Interweave Textiles Limited said the UK had 1,148 hospitals, including 930 National Health Service hospitals and 218 private institutions.

Between the lines: - The report frames pacemakers as part of a larger shift toward connected, individualized cardiac care rather than standalone implants. - Growth in hospital demand suggests the biggest opportunity is not only in device sales, but also in the clinical systems that support implantation and follow-up monitoring. - Regional leadership remains concentrated in North America, but faster growth in Asia-Pacific signals a broadening market as healthcare investment expands.

What’s next: - The market is expected to keep expanding through 2030 as remote monitoring and wireless device features become more common. - Leadless systems and MRI-compatible devices appear positioned to gain more traction as manufacturers push smaller, longer-lasting implants. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards and trend analysis.

The bottom line: - Implantable heart pacemakers are moving from a mature device category into a more connected, patient-specific growth market, with hospital demand and monitoring technology driving the next phase.